HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant factor VIIa for rapid reversal of anticoagulant effect in patients with intracranial hemorrhage: the Israeli experience and review of the literature.

AuthorsNael Da'as, Mudi Misgav, Yossef Kalish, David Varon
JournalThe Israel Medical Association journal : IMAJ (Isr Med Assoc J) Vol. 8 Issue 11 Pg. 807-11 (Nov 2006) ISSN: 1565-1088 [Print] Israel
PMID17180836 (Publication Type: Journal Article, Review)
Chemical References
  • Anticoagulants
  • Recombinant Proteins
  • Vitamin K
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa
Topics
  • Adult
  • Aged
  • Anticoagulants (adverse effects, antagonists & inhibitors, therapeutic use)
  • Factor VII (therapeutic use)
  • Factor VIIa
  • Female
  • Hematoma, Subdural (etiology)
  • Humans
  • Intracranial Hemorrhages (complications, drug therapy, physiopathology)
  • Israel
  • Male
  • Middle Aged
  • Recombinant Proteins (therapeutic use)
  • Stroke (etiology)
  • Vitamin K (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: